Moderna Perpetual Trading | Kritz

Moderna develops medicines using messenger RNA technology. Its business depends on commercial demand for existing products and the progress of candidates through clinical trials and regulatory review.

Market

Perpetual · USDC settled · 10×

Category

U.S. equity